Look no further than GlaxoSmithKline shedding its consumer health arm to form Haleon ... And with talent shortage already a challenge in healthcare and pharma, it’s also important to align ...

Deutsche Bank analyst Emmanuel Papadakis maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of ...

GSK announced several transactions involving the vesting and sale of ordinary shares under its Performance Share Plan and Deferred Investment Award Programme. The transactions involve key executives, ...

The lawsuit, filed under the Arizona Consumer Fraud Act, seeks to hold GSK accountable for violating laws that protect consumers from deceptive and unfair practices. Published first on TheFly ...

CEO Dame Emma Walmsley highlighted that GSK achieved 8% sales growth in 2024, reaching over £31 billion, with specialty medicines driving performance. Core operating profit grew 13%, supporting a ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other stocks. The stock market extended its winning streak on Wednesday, closing firmer as investors ...

Prestige Consumer Healthcare Inc. (NYSE:PBH – Get Free Report)’s share price reached a new 52-week high on Friday after the company announced better than expected quarterly earnings.

The lawsuit claims GlaxoSmithKline replaced Flovent with ... citing the Arizona Consumer Fraud Act, says that the London-based multinational company was motivated by greed when it discontinued ...

GlaxoSmithKline ... selling its consumer business in October, in a deal that could be worth around $15 billion. Speaking in response to questions at the JP Morgan Healthcare Conference, Walmsley ...

For the quarter ended December 2024, Prestige Consumer Healthcare (PBH) reported revenue of $290.32 million, up 2.7% over the same period last year. EPS came in at $1.22, compared to $1.06 in the ...

Thank you for standing by and welcome to Prestige Consumer Healthcare third quarter, 2025 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker ...

Prestige Consumer Healthcare (PBH) came out with quarterly earnings of $1.22 per share, beating the Zacks Consensus Estimate of $1.16 per share. This compares to earnings of $1.06 per share a year ...